Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed COO
Appointed director

BridgeBio Pharma, Inc. (BBIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 1,301 shares @ $29.8, valued at $38.8k
Exercised 3,760 restricted stock units @ $0
08/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2023 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 50,698 shares @ $29.8, valued at $1.5M
Sold 51,552 shares @ $28.5883, valued at $1.5M
Exercised 5,130 restricted stock units @ $0
Exercised 2,394 restricted stock units @ $0
Exercised 61,182 restricted stock units @ $0
Exercised 33,544 restricted stock units @ $0
07/19/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2023 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 50,697 shares @ $14.09, valued at $714.3k
Sold 51,552 shares @ $14.0095, valued at $722.2k
Exercised 5,129 restricted stock units @ $0
Exercised 2,394 restricted stock units @ $0
Exercised 61,182 restricted stock units @ $0
Exercised 33,544 restricted stock units @ $0
05/18/2023 4 HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 1,300 shares @ $14.09, valued at $18.3k
Exercised 3,759 restricted stock units @ $0
05/18/2023 4 STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 20,572 shares @ $14.09, valued at $289.9k
Sold 24,424 shares @ $14.0095, valued at $342.2k
Exercised 1,710 restricted stock units @ $0
Exercised 778 restricted stock units @ $0
Exercised 24,193 restricted stock units @ $0
Exercised 947 restricted stock units @ $0
Exercised 17,368 restricted stock units @ $0
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2023 4 STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 62,692 shares @ $10.9607, valued at $687.1k
03/03/2023 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 120,000 shares @ $10.9602, valued at $1.3M
02/28/2023 3 MCCORMICK FRANK (Director) has filed a Form 3 on BridgeBio Pharma, Inc.
02/23/2023 4 MCCORMICK FRANK (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Granted 158,814 options to buy @ $11.92, valued at $1.9M
02/21/2023 4 SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 1,304 shares @ $12.64, valued at $16.5k
Exercised 3,196 restricted stock units @ $0
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 1,534 shares @ $12.64, valued at $19.4k
Exercised 3,760 restricted stock units @ $0
02/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/21/2023 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 23,908 shares @ $12.64, valued at $302.2k
Sold 44,798 shares @ $12.7031, valued at $569.1k
Exercised 5,129 restricted stock units @ $0
Exercised 2,395 restricted stock units @ $0
Exercised 61,182 restricted stock units @ $0
02/14/2023 4 STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Granted 323,431 options to buy @ $11.41, valued at $3.7M
Granted 277,893 restricted stock units @ $0
02/14/2023 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Granted 624,652 options to buy @ $11.41, valued at $7.1M
Granted 536,704 restricted stock units @ $0
02/06/2023 4 STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 61,040 shares @ $11.0079, valued at $671.9k
02/06/2023 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 120,000 shares @ $11.0058, valued at $1.3M
01/06/2023 4 STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 61,040 shares @ $7.6748, valued at $468.5k
01/06/2023 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Sold 120,000 shares @ $7.6738, valued at $920.9k
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Kumar Neil (CEO and President) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 34,066 shares @ $9.64, valued at $328.4k
Sold 34,640 shares @ $9.3997, valued at $325.6k
Exercised 5,130 restricted stock units @ $0
Exercised 2,394 restricted stock units @ $0
Exercised 61,182 restricted stock units @ $0
11/18/2022 4 STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 10,789 shares @ $9.64, valued at $104k
Sold 19,678 shares @ $9.4006, valued at $185k
Exercised 1,710 restricted stock units @ $0
Exercised 778 restricted stock units @ $0
Exercised 24,193 restricted stock units @ $0
Exercised 3,786 restricted stock units @ $0
11/18/2022 4 SCHELLER RICHARD H (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 1,106 shares @ $9.64, valued at $10.7k
Exercised 3,196 restricted stock units @ $0
11/18/2022 4 HOMCY CHARLES J (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 1,301 shares @ $9.64, valued at $12.5k
Exercised 3,760 restricted stock units @ $0
08/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2022 4 STEPHENSON BRIAN C (Secretary, Treasurer & CFO) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Paid exercise price by delivering 9,227 shares @ $11.08, valued at $102.2k
Exercised 1,709 restricted stock units @ $0
Exercised 778 restricted stock units @ $0
Exercised 24,193 restricted stock units @ $0
08/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Valantine Hannah (Director) has filed a Form 4 on BridgeBio Pharma, Inc.
Txns: Granted 104,921 options to buy @ $8.45, valued at $886.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy